Table 5 List of antimicrobial exposure in patients infected with E.coli and E.faecium
Antimicrobial | E.coli (n,%) | E.faecium (n,%) | E.coli and E.faecium (n,%) |
|---|---|---|---|
Cefperazone-sulbactam | 5(2.72) | 34(18.48) | 5(2.72) |
Cefotaxime-sulbactam | 1(0.54) | 11(5.98) | 1(0.54) |
Ceftazidime | 1(0.54) | 7(3.8) | 2(1.09) |
Ceftriaxone | 3(1.63) | 6(3.26) | 0 |
Cefperazone-tazobactam | 0 | 2(1.09) | 0 |
Cefuroxime | 1(0.54) | 0 | 0 |
Meropenem | 0 | 20(10.87) | 3(1.63) |
Imipenem-cilastatin | 1(0.54) | 4(2.17) | 2(1.09) |
Biapenem | 0 | 3(1.63) | 2(1.09) |
Gentamicin | 1(0.54) | 0 | 1(0.54) |
Amikacin | 0 | 0 | 1(0.54) |
Moxifloxacin | 4(2.17) | 6(3.26) | 1(0.54) |
Levofloxacin | 2(1.09) | 8(4.35) | 2(1.09) |
Piperacillin—tazobactam | 2(1.09) | 12(6.52) | 3(1.63) |
Linezolid | 2(1.09) | 2(1.09) | 0 |
Vancomycin | 2(1.09) | 1(0.54) | 0 |
Tigecycline | 1(0.54) | 5(2.72) | 0 |
Clindamycin | 0 | 1(0.54) | 0 |
Rifampin | 0 | 1(0.54) | 0 |
Metronidazole | 0 | 0 | 1(0.54) |
Ornidazole | 0 | 2(1.09) | 0 |
Fluconazole | 0 | 3(1.63) | 2(1.09) |
Voriconazole | 0 | 2(1.09) | 1(0.54) |
Caspofungin | 0 | 1(0.54) | 0 |
Total | 26(14.13) | 131(71.20) | 27(14.67) |